Provident Wealth Management’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Sell
144,908
-10,762
-7% -$30.5K 0.11% 55
2026
Q1
$377K Hold
155,670
0.11% 52
2025
Q4
$679K Hold
155,670
0.2% 38
2025
Q3
$654K Sell
155,670
-3,197
-2% -$11.4K 0.2% 39
2025
Q2
$456K Hold
158,867
0.15% 46
2025
Q1
$429K Hold
158,867
0.15% 46
2024
Q4
$375K Hold
158,867
0.13% 55
2024
Q3
$377K Buy
158,867
+1,730
+1% +$3.81K 0.13% 56
2024
Q2
$306K Hold
157,137
0.11% 60
2024
Q1
$1.01M Hold
157,137
0.38% 36
2023
Q4
$2.2M Sell
157,137
-178,126
-53% -$2.81M 0.97% 25
2023
Q3
$8.21M Buy
+335,263
New +$8.5M 3.99% 7

Other funds holding GNLX

Provident Wealth Management's GNLX Position: Q2 2026 in Review

Provident Wealth Management reduced its Genelux (GNLX) stake by 6.9% in Q2 2026, selling an estimated $30.5K and leaving 144,908 shares worth $436K. The position accounts for 0.11% of the portfolio, ranked #55.

Provident Wealth Management first reported a position in GNLX in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.21M in Q3 2023. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Provident Wealth Management held 144,908 shares of Genelux worth $436K as of Q2 2026.
  • Provident Wealth Management sold 10,762 Genelux shares in Q2 2026, an estimated $30.5K.
  • Genelux made up 0.11% of Provident Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Provident Wealth Management first reported a position in Genelux in Q3 2023 and has held it in 12 quarters since.
  • Provident Wealth Management's Genelux position peaked at $8.21M in Q3 2023.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Provident Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.